Protein-mapping technology helps identify mutations in drug-resistant cells
28-Feb-2005 -
The Children's Cancer Institute Australia (CCIA) is leading the fight against drug-resistant
cancer using advanced protein-mapping technology from GE Healthcare. Two-dimensional gel technology called DIGE (2-D Fluorescence Difference Gel Electrophoresis), developed by GE Healthcare, is being used ...
chemotherapy
drug resistance
dyes
+4